Thermo Fisher Scientific Stock Börse Stuttgart
Equities
TN8
US8835561023
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
507.2 EUR | -0.29% |
|
+2.86% | +5.98% |
Sales 2024 * | 43B 39.33B | Sales 2025 * | 45.98B 42.05B | Capitalization | 212B 194B |
---|---|---|---|---|---|
Net income 2024 * | 6.18B 5.65B | Net income 2025 * | 6.94B 6.35B | EV / Sales 2024 * | 5.47 x |
Net Debt 2024 * | 23.2B 21.22B | Net Debt 2025 * | 19.14B 17.5B | EV / Sales 2025 * | 5.03 x |
P/E ratio 2024 * |
34.7
x | P/E ratio 2025 * |
29.9
x | Employees | - |
Yield 2024 * |
0.27% | Yield 2025 * |
0.29% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 week | +2.86% | ||
Current month | -0.31% | ||
1 month | -4.63% | ||
3 months | -2.49% | ||
6 months | +1.72% | ||
Current year | +5.98% |
![Extreme 489.5](/images/extremecours_fleche.png)
![Extreme 489.5](/images/extremecours_fleche.png)
![Extreme 393.9](/images/extremecours_fleche.png)
![Extreme 234.85](/images/extremecours_fleche.png)
![Extreme 84.56](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change |
---|---|---|
24-07-17 | 503.5 | -1.00% |
24-07-16 | 508.6 | +1.74% |
24-07-15 | 499.9 | -0.71% |
24-07-12 | 503.5 | +0.79% |
24-07-11 | 499.6 | +1.40% |
Delayed Quote Börse Stuttgart, July 17, 2024 at 09:00 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.88% | 187B | |
+27.41% | 155B | |
+33.89% | 115B | |
+2.24% | 65.5B | |
+14.83% | 52.87B | |
-3.30% | 45.25B | |
-3.52% | 39.7B | |
+6.47% | 37.72B | |
+19.98% | 30.38B |
- Stock Market
- Equities
- TMO Stock
- TN8 Stock